Latest News

Huntington disease prevention trial shows creatine safe, slows progression

The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Genetic change in autism-related gene identified

  • Are cigarette substitutes safe alternative? Depends on user habits

  • Youth who have used e-cigarettes report greater intent to try regular cigarettes

  • Consequences of teen alcohol, marijuana use studied

  • Neurons in human skin perform advanced calculations

  • Why plants in the office make us more productive

  • How neurons in bats' brains ensure a safe flight

  • Childhood adoption experiences: Effect later in adulthood

  • Family dinners good for teens' mental health, could protect from cyberbullying

  • Protein glue shows potential for use with biomaterials

  •